EUVIMEDEUVIMED entdecken
Open Access

Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells

Morgan J Coombs, Tyrone Dowdy, Md Masud Alam, Helena Muley Vilamú, Seketoulie Keretsu, Guzal Khayrullina, Orieta Celiku iD, Alexander Y Mitrophanov, Vibhuti Joshi, Jinkyu Jung, Ayaka Hara, Emily E Steffke und 10 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Morgan J Coombs und 21 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Hauptthemen laut MEDLINE: Glioblastoma, Natural Killer T-Cells, Brain Neoplasms, Glycosphingolipids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, CCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To develop effective therapies for glioblastoma (GBM), a deeper understanding of its underlying immunoregulatory mechanisms is needed. Invariant natural killer T (iNKT) cells are unconventional T cells that recognize lipid antigens and are known to regulate tumor immunity in other cancer types. Given the lipid-rich nature of the brain and the unique metabolic activity of GBM cells, we hypothesized that GBM-enriched lipids could direct iNKT cells to contribute to the immunosuppressive nature of the disease.

Methods

Lipid levels of multiple human GBM stem-like cell (GSC) lines, low grade-glioma lines, and normal human astrocytes were determined using liquid-chromatography mass spectrometry. GBM stem-like cell-enriched lipids were tested in iNKT stimulation assays, with either human iNKT cell lines or PBMC samples from both healthy donors and GBM patients, to determine antigenicity and characterize the nature of iNKT activation.

Results

Multiple lipid species were found to be uniquely enriched in GSCs. Many of these lipids, called sulfatides, were recognized by and activated iNKT cells in a dose-dependent manner when presented by CD1d. Pharmaceutical and genetic targeting of the sulfatide synthetic pathway within GSCs resulted in an altered ability to activate iNKT cells. However, one lipid, lyso-sulfatide, inhibited the activation of iNKT cells and suppressed activation induced by a cognate antigen, α-galactosylceramide.

Conclusions

The modulation of iNKT cell functions by GSC-enriched glycosphingolipids may contribute to the immunosuppression of GBM and highlights sulfatide production as a potential therapeutic target for GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNatural Killer T-CellsBrain NeoplasmsGlycosphingolipidsHumansLymphocyte ActivationTumor Cells, CulturedAntigens, CD1dNeoplastic Stem CellsSulfoglycosphingolipids

Stichwörter der Autor:innen

glioblastoma metabolismiNKT cellslipid antigenssulfatides

Substanzen

GlycosphingolipidsAntigens, CD1dSulfoglycosphingolipids

Autor:innen und Institutionen

  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland.
  • Department of Medical Microbiology & Immunology, University of Wisconsin-Madison, Madison, Wisconsin.

ORCID-Profile: Orieta Celiku, Mioara Larion, Masaki Terabe

Förderung

  • NIH HHS
  • NCI NIH HHS
  • CCR NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Center for Cancer Research

Zitieren

APA

Coombs, M. J., Dowdy, T., Alam, M. M., Vilamú, H. M., Keretsu, S., Khayrullina, G., Celiku, O., Mitrophanov, A. Y., Joshi, V., Jung, J., Hara, A., Steffke, E. E., Latifi, L., Kim, H., Spurgeon, J., Malik, N., Hancock, J. C., Ozer, B. H., Gilbert, M. R., …, & Terabe, M. (2025). Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf135

Vancouver

Coombs MJ, Dowdy T, Alam MM, Vilamú HM, Keretsu S, Khayrullina G, et al. Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf135

BibTeX
@article{Coombs2025,
  author = {Coombs, Morgan J and Dowdy, Tyrone and Alam, Md Masud and Vilamú, Helena Muley and Keretsu, Seketoulie and Khayrullina, Guzal and Celiku, Orieta and Mitrophanov, Alexander Y and Joshi, Vibhuti and Jung, Jinkyu and Hara, Ayaka and Steffke, Emily E and Latifi, Laila and Kim, Hye and Spurgeon, Jo and Malik, Nargis and Hancock, John C and Ozer, Byram H and Gilbert, Mark R and Gumperz, Jenny and Larion, Mioara and Terabe, Masaki},
  title = {Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf135}
}
Kostenlos starten →